Boots first half
This article was originally published in The Rose Sheet
Executive Summary
Boots Healthcare International sales rose 7.6% in the first half, British company reports Sept. 29. In addition, "The proposed disposal of BHI is on track," firm notes. Boots announced it would divest its OTC consumer business in April (1"The Rose Sheet" April 11, 2005, p. 9). Boots the Chemists net sales were up 1.1%, but declined 1.3% on a like-for-like basis...